![Michael Sofia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Sofia
Corporate Officer/Principal chez
Baruch S. Blumberg Institute
Profil
Michael J.
Sofia was the founder of Arbutus Biopharma, Inc., founded in 2012, where the title held was Chief Scientific Officer & Head-Research.
Dr. Sofia is currently a Professor at Baruch S.
Blumberg Institute since 2012.
Former jobs include Group Director-New Leads Chemistry at Bristol-Myers Squibb Pharma Research Labs LLC from 1999 to 2005; Senior Vice President-Chemistry at Pharmasset, Inc. from 2005 to 2012; Senior Vice President-Chemistry at Gilead Sciences, Inc. in 2012; Vice President-Research at Transcell Technology, Inc. from 1993 to 1999; Vice President-Research at Intercardia Research Labs; and Chief Scientific Officer at Arbutus Biopharma Corp.
from 2015 to 2024.
Education includes undergraduate studies at Cornell University and a doctorate from the University of Illinois At Urbana–Champaign.
Postes actifs de Michael Sofia
| Sociétés | Poste | Début |
|---|---|---|
Baruch S. Blumberg Institute
 Baruch S. Blumberg Institute The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block. | Corporate Officer/Principal | 01/04/2012 |
Anciens postes connus de Michael Sofia
| Sociétés | Poste | Fin |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Directeur Technique/Scientifique/R&D | 31/12/2024 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/12/2012 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Corporate Officer/Principal | 01/02/2012 |
Bristol-Myers Squibb Pharma Research Labs LLC
 Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Researches & develops drugs and related pharmaceutical products | Corporate Officer/Principal | 01/01/2005 |
Transcell Technology, Inc.
 Transcell Technology, Inc. Industrial MachineryProducer Manufacturing Manufactures load cells, postal scales, precision balances, and industrial scales | Corporate Officer/Principal | 01/05/1999 |
Formation de Michael Sofia
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Health Technology |
Bristol-Myers Squibb Pharma Research Labs LLC
Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Researches & develops drugs and related pharmaceutical products | Commercial Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transcell Technology, Inc.
Transcell Technology, Inc. Industrial MachineryProducer Manufacturing Manufactures load cells, postal scales, precision balances, and industrial scales | Producer Manufacturing |
Baruch S. Blumberg Institute
Baruch S. Blumberg Institute The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block. | |
Intercardia Research Labs | |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
